Literature DB >> 16517908

Use of Sno Strip filter-paper wicks for collection of genital-tract samples allows reproducible determination of human immunodeficiency virus type 1 (HIV-1) RNA viral load with a commercial HIV-1 viral load assay.

Christopher H Sherlock1, Paula M Lott, Deborah M Money, Linda Merrick, Yasemin Arikan, Valencia P Remple, Kevin Craib, David R Burdge.   

Abstract

To assess the reproducibility of measurements of cervical and vaginal human immunodeficiency virus (HIV) viral load, 92 duplicate cervical and 88 duplicate vaginal samples were collected from 13 HIV-infected women using Sno Strip filter-paper wicks. RNA was eluted from the strips, extracted, and assayed using a modified protocol for the Roche Cobas Amplicor HIV-1 Monitor assay. Pearson's correlation coefficient (R), coefficient of determination (D), and Bland-Altman plots (BA) were used to compare paired log10-transformed viral loads. Analysis of duplicate same-site samples showed good reproducibility (cervix: R = 0.72, D = 52%, BA = 89% within range; vagina: R = 0.72, D = 51%, BA = 87% within range); paired cervix/vagina measurements showed moderate correlation only (R = 0.56; D = 31.3%). Standardized sample collection and simple modification of the Roche Cobas Amplicor HIV-1 Monitor assay allows reproducible measurement of genital viral load.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517908      PMCID: PMC1393121          DOI: 10.1128/JCM.44.3.1115-1119.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions.

Authors:  G C John; H Sheppard; D Mbori-Ngacha; R Nduati; D Maron; M Reiner; J Kreiss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-02-01       Impact factor: 3.731

2.  Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team.

Authors:  P S Reichelderfer; R W Coombs; D J Wright; J Cohn; D N Burns; S Cu-Uvin; P A Baron; M H Coheng; A L Landay; S K Beckner; S R Lewis; A A Kovacs
Journal:  AIDS       Date:  2000-09-29       Impact factor: 4.177

3.  Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model.

Authors:  H Chakraborty; P K Sen; R W Helms; P L Vernazza; S A Fiscus; J J Eron; B K Patterson; R W Coombs; J N Krieger; M S Cohen
Journal:  AIDS       Date:  2001-03-30       Impact factor: 4.177

4.  The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.

Authors:  C C Wang; R S McClelland; M Reilly; J Overbaugh; S R Emery; K Mandaliya; B Chohan; J Ndinya-Achola; J Bwayo; J K Kreiss
Journal:  J Infect Dis       Date:  2001-02-28       Impact factor: 5.226

5.  Comparison of two amplification technologies for detection and quantitation of human immunodeficiency virus type 1 RNA in the female genital tract. Division of AIDS Treatment Research Initiative 009 Study Team.

Authors:  J Bremer; M Nowicki; S Beckner; D Brambilla; M Cronin; S Herman; A Kovacs; P Reichelderfer
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

6.  Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.

Authors:  R W Coombs; D J Wright; P S Reichelderfer; D N Burns; J Cohn; S Cu-Uvin; P A Baron; M H Cohen; A L Landay; S Lewis; A Kovacs
Journal:  J Infect Dis       Date:  2001-09-13       Impact factor: 5.226

7.  Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract.

Authors:  S Cu-Uvin; J W Hogan; A M Caliendo; J Harwell; K H Mayer; C C Carpenter
Journal:  Clin Infect Dis       Date:  2001-08-10       Impact factor: 9.079

8.  Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group.

Authors:  P Baron; J Bremer; S S Wasserman; M Nowicki; B Driscoll; B Polsky; A Kovacs; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

9.  Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Authors:  R Chuachoowong; N Shaffer; W Siriwasin; P Chaisilwattana; N L Young; P A Mock; S Chearskul; N Waranawat; T Chaowanachan; J Karon; R J Simonds; T D Mastro
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

10.  Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract.

Authors:  C E Hart; J L Lennox; M Pratt-Palmore; T C Wright; R F Schinazi; T Evans-Strickfaden; T J Bush; C Schnell; L J Conley; K A Clancy; T V Ellerbrock
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

View more
  1 in total

1.  High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy.

Authors:  Shanmugam Saravanan; Selvamurthi Gomathi; Allison Delong; Bagavathi Kausalya; Sathasivam Sivamalar; Selvamuthu Poongulali; Katherine Brooks; Nagalingeswaran Kumarasamy; Pachamuthu Balakrishnan; Sunil S Solomon; Susan Cu-Uvin; Rami Kantor
Journal:  J Antimicrob Chemother       Date:  2018-08-01       Impact factor: 5.790

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.